UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 5, 2021

Accession Number:
Submission Type:
CIK: 0001335105 Company Name: LIXTE BIOTECHNOLOGY HOLDINGS, INC. File Number: 333-252430